Nice, the Italian company behind security brands abode and Hysecurity, has acquired Carlsbad, Calif.-based Nortek Control for $285 million. Nortek, which is most known in the security industry for its ...

Add Yahoo as a preferred source to see more of our stories on Google. Modern glaucoma treatments can only preserve a patient's current level of vision, offering no hope of restoration. A new Phase 1 ...

My biggest pet peeve with meeting apps is that each one has a different shortcut for muting your mic or turning off your webcam. It’s hard to remember which keys do what when you’re mid-meeting and ...

Leafcutter ants live in highly organized colonies where every ant has a job, and now researchers can flip those jobs like a switch. By manipulating just two neuropeptides, scientists can turn ...

Watch a subscriber-only discussion exploring longevity's new focus. Available only for MIT Alumni and subscribers. Listen to the session or watch below Billions of dollars are flooding into efforts to ...

Ford Motor Co. took an unusually human approach to fixing its stubborn quality problems: It brought back what it calls “gray beard” engineers to help train younger staff and to reprogram the ...

With more than 15 years of experience crafting content about all aspects of personal finance, Michael Benninger knows how to identify smart moves for your money. His work has been published by Intuit, ...

Microsoft has added a new feature called Voice Access to the latest build of Windows 11. Using this feature, users can control their computers via voice commands and extend the speech-recognition ...

Apple, Google, and Microsoft all offer free parental control apps or settings to help you keep your kids safer online. We walk you through the benefits and drawbacks of each. I review privacy tools ...

In this guide, we will see how to reset the printer to its factory default settings. The following are the devices we will discuss. Let us start with one of the biggest brands in the electronic ...

Here’s what you’ll learn when you read this story: Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is ...